Janssen&Janssen schreef op 17 februari 2021 18:17:
[...]
Ik vind onderstaande voorwaarden om mee te mogen doen aan de trial (nu goed geschreven he expert) veel zeggend over de toekomstige kracht van Ruconest.
Cardiovascular disease includes a history of coronary artery disease, cerebrovascular disease, peripheral artery disease, rheumatic heart disease, congenital heart disease and of recent (< 3 months) deep vein thrombosis or pulmonary embolism. Chronic pulmonary disease includes a history of chronic obstructive pulmonary disease, asthma, occupational lung disease, interstitial lung disease or of pulmonary hypertension. Chronic renal disease is defined as a history of an estimated glomerular filtration rate (according to the Chronic Kidney Disease Epidemiology Collaboration equation) < 60ml/min/1.73 m2 for at least three months.